TriSalus Life Sciences (TLSI) Treasury Shares (2020 - 2026)

TriSalus Life Sciences' Treasury Shares history runs 7 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• On a quarterly basis, Treasury Shares fell 92.21% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $1.8 million, a 92.21% decrease from a year earlier, with the FY2025 full-year figure at $1.8 million, up 297.65% from the prior year.
• Treasury Shares eased to $1.8 million in Q1 2026 per TLSI's latest filing, from $1.8 million in the prior quarter.
• Across five years, Treasury Shares topped out at $25.2 million in Q4 2023 and bottomed at $459357.0 in Q4 2024.
• The 5-year median for Treasury Shares is $22.6 million (2025), against an average of $13.8 million.
• Biggest YoY gain for Treasury Shares was 3446.74% in 2024; the steepest drop was 98.18% in 2024.
• Year by year, Treasury Shares stood at $25.0 million in 2022, then gained by 0.95% to $25.2 million in 2023, then plunged by 98.18% to $459357.0 in 2024, then surged by 297.65% to $1.8 million in 2025, then decreased by 2.9% to $1.8 million in 2026.
• Per Business Quant, the three latest TLSI Treasury Shares figures stand at $1.8 million (Q1 2026), $1.8 million (Q4 2025), and $22.6 million (Q2 2025).